Specifically, the Philadelphia chromosome is a variant of chromosome ... these patients would certainly experience devastating side effects. Such a general assault on the human body would not ...

Dasatinib is a potent dual Abl/Src inhibitor approved for treatment of Philadelphia chromosome-positive (Ph-positive) leukemias. At a once-daily dose and a relatively short half-life of 3–5 h ...